Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1993 Aug;48(8):812–816. doi: 10.1136/thx.48.8.812

Effect of amiloride and saline on nasal mucociliary clearance and potential difference in cystic fibrosis and normal subjects.

P G Middleton 1, D M Geddes 1, E W Alton 1
PMCID: PMC464707  PMID: 8211871

Abstract

BACKGROUND--Mucociliary clearance is an important component of pulmonary defence. Maximum clearance is thought to depend on an optimal depth of the sol layer, allowing the most efficient interaction between the cilia and the overlying mucus layer. Sodium absorption, the major ion transport in human airways, is thought to be important in the regulation of the depth of the sol layer. In the airways of patients with cystic fibrosis sodium absorption is increased and mucociliary clearance decreased. Amiloride, a sodium channel blocker, has been shown to improve pulmonary mucociliary clearance in patients with cystic fibrosis. However, its effects on nasal mucociliary clearance in either normal subjects or those with cystic fibrosis are unknown. A study was therefore performed to investigate whether nebulised amiloride improves nasal mucociliary clearance in normal or cystic fibrosis subjects. METHODS--Nasal mucociliary clearance was measured by the saccharin clearance technique in 12 normal subjects and 12 with cystic fibrosis. For the control study measurements were made on two consecutive days and the mean time for each subject averaged. For the drug study measurements were also made on two consecutive days, after administration of nasally nebulised amiloride or placebo (saline) in a double blind manner. Nasal potential difference was measured in eight patients with cystic fibrosis after the administration of amiloride or placebo to assess the efficacy of deposition and duration of action. RESULTS--Baseline values of mucociliary clearance were significantly faster in the normal subjects than in those with cystic fibrosis. In both groups mucociliary clearance was increased after both saline and amiloride, with no significant difference between either treatment. As previously reported, baseline nasal potential difference was significantly more negative in the subjects with cystic fibrosis. Amiloride significantly reduced the potential difference for at least 60 minutes in these subjects. CONCLUSIONS--Nebulised saline significantly improves nasal mucociliary clearance in both normal subjects and those with cystic fibrosis. Amiloride did not appear to exert any additional effects in either group of subjects, despite evidence of its efficacy of deposition.

Full text

PDF
812

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alton E. W., Currie D., Logan-Sinclair R., Warner J. O., Hodson M. E., Geddes D. M. Nasal potential difference: a clinical diagnostic test for cystic fibrosis. Eur Respir J. 1990 Sep;3(8):922–926. [PubMed] [Google Scholar]
  2. Andersen I., Camner P., Jensen P. L., Philipson K., Proctor D. F. A comparison of nasal and tracheobronchial clearance. Arch Environ Health. 1974 Nov;29(5):290–293. doi: 10.1080/00039896.1974.10666589. [DOI] [PubMed] [Google Scholar]
  3. App E. M., King M., Helfesrieder R., Köhler D., Matthys H. Acute and long-term amiloride inhalation in cystic fibrosis lung disease. A rational approach to cystic fibrosis therapy. Am Rev Respir Dis. 1990 Mar;141(3):605–612. doi: 10.1164/ajrccm/141.3.605. [DOI] [PubMed] [Google Scholar]
  4. Egan M., Flotte T., Afione S., Solow R., Zeitlin P. L., Carter B. J., Guggino W. B. Defective regulation of outwardly rectifying Cl- channels by protein kinase A corrected by insertion of CFTR. Nature. 1992 Aug 13;358(6387):581–584. doi: 10.1038/358581a0. [DOI] [PubMed] [Google Scholar]
  5. Kleyman T. R., Cragoe E. J., Jr Amiloride and its analogs as tools in the study of ion transport. J Membr Biol. 1988 Oct;105(1):1–21. doi: 10.1007/BF01871102. [DOI] [PubMed] [Google Scholar]
  6. Knowles M. R., Church N. L., Waltner W. E., Yankaskas J. R., Gilligan P., King M., Edwards L. J., Helms R. W., Boucher R. C. A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis. N Engl J Med. 1990 Apr 26;322(17):1189–1194. doi: 10.1056/NEJM199004263221704. [DOI] [PubMed] [Google Scholar]
  7. Knowles M. R., Church N. L., Waltner W. E., Yankaskas J. R., Gilligan P., King M., Edwards L. J., Helms R. W., Boucher R. C. Aerosolized amiloride as treatment of cystic fibrosis lung disease: a pilot study. Adv Exp Med Biol. 1991;290:119–132. doi: 10.1007/978-1-4684-5934-0_14. [DOI] [PubMed] [Google Scholar]
  8. Knowles M., Gatzy J., Boucher R. Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis. N Engl J Med. 1981 Dec 17;305(25):1489–1495. doi: 10.1056/NEJM198112173052502. [DOI] [PubMed] [Google Scholar]
  9. Köhler D., App E., Schmitz-Schumann M., Würtemberger G., Matthys H. Inhalation of amiloride improves the mucociliary and the cough clearance in patients with cystic fibroses. Eur J Respir Dis Suppl. 1986;146:319–326. [PubMed] [Google Scholar]
  10. Mentz W. M., Brown J. B., Friedman M., Stutts M. J., Gatzy J. T., Boucher R. C. Deposition, clearance, and effects of aerosolized amiloride in sheep airways. Am Rev Respir Dis. 1986 Nov;134(5):938–943. doi: 10.1164/arrd.1986.134.5.938. [DOI] [PubMed] [Google Scholar]
  11. Potter J. L., Matthews L. W., Spector S., Lemm J. Studies on pulmonary secretions. II. Osmolality and the ionic environment of pulmonary secretions from patients with cystic fibrosis, bronchiectasis, and laryngectomy. Am Rev Respir Dis. 1967 Jul;96(1):83–87. doi: 10.1164/arrd.1967.96.1.83. [DOI] [PubMed] [Google Scholar]
  12. Puchelle E., Aug F., Pham Q. T., Bertrand A. Comparison of three methods for measuring nasal mucociliary clearance in man. Acta Otolaryngol. 1981 Mar-Apr;91(3-4):297–303. doi: 10.3109/00016488109138511. [DOI] [PubMed] [Google Scholar]
  13. Quinlan M. F., Salman S. D., Swift D. L., Wagner H. N., Jr, Proctor D. F. Measurement of mucociliary function in man. Am Rev Respir Dis. 1969 Jan;99(1):13–23. doi: 10.1164/arrd.1969.99.1.13. [DOI] [PubMed] [Google Scholar]
  14. Quinton P. M. Cystic fibrosis: a disease in electrolyte transport. FASEB J. 1990 Jul;4(10):2709–2717. doi: 10.1096/fasebj.4.10.2197151. [DOI] [PubMed] [Google Scholar]
  15. Rutland J., Cole P. J. Nasal mucociliary clearance and ciliary beat frequency in cystic fibrosis compared with sinusitis and bronchiectasis. Thorax. 1981 Sep;36(9):654–658. doi: 10.1136/thx.36.9.654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Rutland J., Griffin W., Cole P. Nasal brushing and measurement of ciliary beat frequency. An in vitro method for evaluating pharmacologic effects on human cilia. Chest. 1981 Dec;80(6 Suppl):865–867. doi: 10.1378/chest.80.6.865. [DOI] [PubMed] [Google Scholar]
  17. Stanley P. J., Wilson R., Greenstone M. A., Mackay I. S., Cole P. J. Abnormal nasal mucociliary clearance in patients with rhinitis and its relationship to concomitant chest disease. Br J Dis Chest. 1985 Jan;79(1):77–82. doi: 10.1016/0007-0971(85)90010-5. [DOI] [PubMed] [Google Scholar]
  18. Stanley P., MacWilliam L., Greenstone M., Mackay I., Cole P. Efficacy of a saccharin test for screening to detect abnormal mucociliary clearance. Br J Dis Chest. 1984 Jan;78(1):62–65. [PubMed] [Google Scholar]
  19. Willumsen N. J., Boucher R. C. Sodium transport and intracellular sodium activity in cultured human nasal epithelium. Am J Physiol. 1991 Aug;261(2 Pt 1):C319–C331. doi: 10.1152/ajpcell.1991.261.2.C319. [DOI] [PubMed] [Google Scholar]
  20. Wong L. B., Miller I. F., Yeates D. B. Pathways of substance P stimulation of canine tracheal ciliary beat frequency. J Appl Physiol (1985) 1991 Jan;70(1):267–273. doi: 10.1152/jappl.1991.70.1.267. [DOI] [PubMed] [Google Scholar]
  21. Yeates D. B., Sturgess J. M., Kahn S. R., Levison H., Aspin N. Mucociliary transport in trachea of patients with cystic fibrosis. Arch Dis Child. 1976 Jan;51(1):28–33. doi: 10.1136/adc.51.1.28. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES